Health
Mercy BioAnalytics Appoints Dr. Prasanth Reddy as Chief Medical Officer
Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Prasanth Reddy, M.D. MPH, FACP, as its Chief Medical Officer. Dr. Reddy brings critical experience in precision oncology, product development, and patient access, and will play a pivotal role in advancing Mercy's mission to save lives and relieve suffering through early cancer detection.
About this update from Labcorp Holdings Inc.
[{"type":"text","content":"WALTHAM, Mass., July 8, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Prasanth Reddy, M.D. MPH, FACP, as its Chief Medical Officer. Dr. Reddy brings critical experience in precision oncology, product development, and patient access, and will play a pivotal role in advancing Mercy's mission to save lives and relieve suffering through early cancer detection.","length":490,"tagName":"p"},{"type":"image","alt":"Mercy BioAnalytics (PRNewsfoto/Mercy BioAnalytics)","displaySize":"","headline":null,"caption":"Mercy BioAnalytics (PRNewsfoto/Mercy BioAnalytics)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/4ee0e96538779c5e48b88c8d50192afe"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0PKuiPEDenDZXdUFzXYNeA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/4ee0e96538779c5e48b88c8d50192afe","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2395693/mercy_logo_color_resized_cropped_4K_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Reddy is a distinguished physician and executive with more than 25 years of experience across clinical practice and biotech leadership and is triple board-certified in internal medicine, medical oncology, and hematology. He most recently served as the Global Head of Enterprise Oncology at LabCorp, where he led the integration of genomic profiling capabilities including the acquisitions of OmniSeq and PGDx. Prior to this role, he was the VP of Medical Affairs at Foundation Medicine, where he led the development and execution of medical strategy worldwide, advancing the clinical adoption of precision oncology through data-driven evidence generation, KOL engagement, and strategic collaborations.","length":705,"tagName":"p"},{"type":"text","content":"Dr. Reddy earned his medical degree from the University of Kansas Medical Center, where he also completed his residency in internal medicine and fellowship in hematology and oncology. He holds a Master of Public Health from the University of Kansas and is an alumnus of Harvard Business School. Dr. Reddy also serves as a Lieutenant Colonel in the U.S. Air ...